SEZABY is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Sun Pharmaceutical Industries, Inc.. The primary component is Phenobarbital Sodium.
| Product ID | 62756-301_6ac5c671-68ab-4347-9cd6-1fd6ef32b069 |
| NDC | 62756-301 |
| Product Type | Human Prescription Drug |
| Proprietary Name | SEZABY |
| Generic Name | Phenobarbital Sodium |
| Dosage Form | Injection |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2022-12-25 |
| Marketing Category | NDA / |
| Application Number | NDA215910 |
| Labeler Name | Sun Pharmaceutical Industries, Inc. |
| Substance Name | PHENOBARBITAL SODIUM |
| Active Ingredient Strength | 100 mg/1 |
| DEA Schedule | CIV |
| NDC Exclude Flag | N |
| Listing Certified Through | 2024-12-31 |
| Marketing Start Date | 2022-12-26 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 62756-301 | SEZABY | phenobarbital sodium |
| 0641-0476 | Phenobarbital Sodium | Phenobarbital Sodium |
| 0641-0477 | Phenobarbital Sodium | Phenobarbital Sodium |
| 14789-127 | Phenobarbital Sodium | Phenobarbital Sodium |
| 14789-128 | Phenobarbital Sodium | Phenobarbital Sodium |
| 42494-415 | Phenobarbital Sodium | Phenobarbital Sodium |
| 42494-416 | Phenobarbital Sodium | Phenobarbital Sodium |
| 54288-136 | Phenobarbital Sodium | Phenobarbital Sodium |
| 54288-137 | Phenobarbital Sodium | Phenobarbital Sodium |
| 63629-1997 | Phenobarbital Sodium | Phenobarbital Sodium |
| 63629-1998 | Phenobarbital Sodium | Phenobarbital Sodium |
| 63629-2007 | Phenobarbital Sodium | Phenobarbital Sodium |
| 63629-2008 | Phenobarbital Sodium | Phenobarbital Sodium |
| 75834-288 | Phenobarbital Sodium | Phenobarbital Sodium |
| 75834-289 | Phenobarbital Sodium | Phenobarbital Sodium |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() SEZABY 97098882 not registered Live/Pending |
Sun Pharma Advanced Research Company Limited 2021-10-29 |